Recall: D-0826-2021

Class II - Potentially Harmful

Class IIClassification

2021-08-27Initiated

TerminatedStatus

Glenmark Pharmaceuticals Inc.,Firm

Product

Zonisamide Capsules USP 100 mg Rx Only Manufactured by: Glenmark Pharmaceuticals Inc., USA Monroe, NC 28110 Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 a) 100 Capsules NDC 68462-130-01; b) 500 Capsules NDC 68462-130-05

Reason

CGMP Deviations

Distribution

Nationwide.

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.